Suppr超能文献

人参汤中共存多糖增强人参皂苷全身暴露的肠道微生物群相关机制。

Gut microbiota-involved mechanisms in enhancing systemic exposure of ginsenosides by coexisting polysaccharides in ginseng decoction.

作者信息

Zhou Shan-Shan, Xu Jun, Zhu He, Wu Jie, Xu Jin-Di, Yan Ru, Li Xiu-Yang, Liu Huan-Huan, Duan Su-Min, Wang Zhuo, Chen Hu-Biao, Shen Hong, Li Song-Lin

机构信息

Department of Pharmaceutical Analysis, Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, PR China.

Department of Metabolomics, Jiangsu Province Academy of Traditional Chinese Medicine and Jiangsu Branch of China Academy of Chinese Medical Sciences, Nanjing, Jiangsu, PR China.

出版信息

Sci Rep. 2016 Mar 2;6:22474. doi: 10.1038/srep22474.

Abstract

Oral decoctions of traditional Chinese medicines (TCMs) serve for therapeutic and prophylactic management of diseases for centuries. Small molecules and polysaccharides are the dominant chemicals co-occurred in the TCM decoction. Small molecules are well-studied by multidisciplinary elaborations, whereas the role of polysaccharides remains largely elusive. Here we explore a gut microbiota-involved mechanism by which TCM polysaccharides restore the homeostasis of gut microbiota and consequently promote the systemic exposure of concomitant small molecules in the decoction. As a case study, ginseng polysaccharides and ginsenosides in Du-Shen-Tang, the decoction of ginseng, were investigated on an over-fatigue and acute cold stress model. The results indicated that ginseng polysaccharides improved intestinal metabolism and absorption of certain ginsenosides, meanwhile reinstated the perturbed holistic gut microbiota, and particularly enhanced the growth of Lactobacillus spp. and Bacteroides spp., two major metabolic bacteria of ginsenosides. By exploring the synergistic actions of polysaccharides with small molecules, these findings shed new light on scientization and rationalization of the classic TCM decoctions in human health care.

摘要

几个世纪以来,中药汤剂一直用于疾病的治疗和预防。小分子和多糖是中药汤剂中同时存在的主要化学成分。小分子已通过多学科研究得到充分了解,而多糖的作用在很大程度上仍不明确。在此,我们探索了一种涉及肠道微生物群的机制,通过该机制,中药多糖可恢复肠道微生物群的稳态,从而促进汤剂中伴随的小分子的全身暴露。作为一个案例研究,在过度疲劳和急性冷应激模型上研究了人参汤(人参汤剂)中的人参多糖和人参皂苷。结果表明,人参多糖改善了某些人参皂苷的肠道代谢和吸收,同时恢复了受干扰的整体肠道微生物群,特别是促进了人参皂苷的两种主要代谢细菌——乳酸杆菌属和拟杆菌属的生长。通过探索多糖与小分子的协同作用,这些发现为经典中药汤剂在人类医疗保健中的科学化和合理化提供了新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f837/4774164/be2696f76ddc/srep22474-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验